Home / Clinical Laboratory / Controls / Quality Control / Antibody Test Quality Control Access® SARS-CoV-2 IgG II 2 Levels 6 X 4 mLC69059
Picture of Antibody Test Quality Control Access® SARS-CoV-2 IgG II 2 Levels 6 X 4 mLC69059

Antibody Test Quality Control Access® SARS-CoV-2 IgG II 2 Levels 6 X 4 mLC69059

Antibody-Test-Quality-Control-Access®-SARS-CoV-2-IgG-II-2-Levels-6-X-4-mLC69059

SKU #

#1183728

MPN #

C69059

Brand

Beckman Coulter

Stock

In Stock

Quantity

100

Features

CONTROL, ACCESS SARS-COV-2 IGG II QC (1/BX) D/S

$381.43 USD

Attribute Name Attribute Value
McKesson # 1183728
Manufacturer # C69059
Brand Access®
Manufacturer Beckman Coulter
Application Quality Control
Container Type Vial
For Use With For Monitoring System Performance of the Access SARS-CoV-2 IgG II Assay using the Access Immunoassay Systems only
Levels 2 Levels
Test Name SARS-CoV-2 IgG II
Test Type Antibody Test
UNSPSC Code 41116128
Volume 6 X 4 mL

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • This test has not been reviewed by the FDA
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high or moderate complexity tests
  • For U.S.A. only, Federal law restricts this device to sale and distribution by or on the order of a physician, or to a clinical laboratory; and use is restricted to by or on the order of a physician
  • Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities
  • Negative results do not preclude acute SARS-CoV-2 infection
  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E
  • QC1-QC2, 4 mL/vial, 3 vials each level